news
01.06.09
Professor Zhihao Sun joins GBL as a Scientific Advisor
Zhihao Sun is a Professor at the School of Biotechnology and Principal Investigator at the Biocatalysis Laboratory,
Prior to joining
Sean Sutcliffe, CEO comments: "We are honoured that Professor Sun is joining the Green Biologic's team. He is leading authority on the Chinese ABE process and brings a wealth of practical "hands on" process experience that will help us commercialise our advanced fermentation technology".
01.03.09
Dr Gerald Chan joins Board as Non Executive Director
Green Biologics (GBL) is delighted to announce that Dr Gerald Chan has joined the Board of GBL. This appointment comes alongside the completion of an investment round to continue the development of GBL's commercialization programme, in which Morningside participated alongside existing investors including Oxford Capital Partners and Carbon Trust Investments.
Dr Andrew Rickman, Chairman, commented, "We are delighted to welcome Dr Gerald Chan and Morningside to GBL. We particularly welcome the depth of experience that Gerald and Morningside bring to our successful commercialization programme in China, which is a key focus for the company, as well as their experience of nurturing successful global technology companies."
Gerald Chan co-founded Morningside in 1986. As a privately-held investment group, Morningside is active in both private equity and venture capital investments in North America, Europe and
Dr. Chan is currently a board member of Hang Lung Group and servesontheboards ofseveralprivatebiotechnology companies including Serica, Inc., Critical Biologics Corporation, CellCentric, Ltd., Inimex Pharmaceuticals, Inc.,Stealth Peptides Inc., and Vaccine Technologies Inc. Dr. Chan sits on the Science Advisory Council of UCLA, the Global Advisory Committee of the International Society for Stem Cell Research, the advisory board of
23.02.09
Professor David Jones joins GBL as a Scientific Advisor
Green Biologics Ltd (GBL) has appointed Professor David Jones as Scientific Advisor. David is a world leading expert on solventogenic Clostridia and their industrial application for the production of acetone, butanol and ethanol (ABE).
David has retired after a distinguished academic career with the Department of Microbiology,
Dr